ACE2 and hepatocellular carcinoma: The mRNA expression of ACE2 was related to some clinical parameters – age, AFP level and cirrhosis – of the HCC patients, it was also found to be associated with the prognoses of HCC patients, where the potential clinical value of ACE2 expression could be seen.